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Abstract To identify possible ligands of the orphan somatos-
tatin-like receptor 1 (SLC-1), rat brain extracts were analyzed
by using the functional expression system of Xenopus oocytes
injected with cRNAs encoding SLC-1 and G protein-gated
inwardly rectifying potassium channels (GIRK). A strong inward
current was observed with crude rat brain extracts which upon
further purification by cation exchange chromatography and
high performance liquid chromatography (HPLC) yielded two
peptides with a high agonist activity. Mass spectrometry and
partial peptide sequencing revealed that one peptide is identical
with the neuropeptide melanin concentrating hormone (MCH),
the other represents a truncated version of MCH lacking the
three N-terminal amino acid residues. Xenopus oocytes expres-
sing the MCH receptor responded to nM concentrations of
synthetic MCH not only by the activation of GIRK-mediated
currents but also by the induction of Ca2 dependent chloride
currents mediated by phospholipase C. This indicates that the
MCH receptor can couple either to the Gi- or Gq-mediated signal
transduction pathway, suggesting that MCH may serve for a
number of distinct brain functions including food uptake
behavior.
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1. Introduction
Many neurotransmitter receptors occur in numerous di¡er-
ent subtypes. This is particularly true for the G protein-
coupled receptors (GPCRs) of the somatostatin and opioid
receptor family [1]. Five somatostatin receptors (SSTR1^5)
and four opioid receptors (OR-W, OR-N, OR-U and OR-FQ)
have been identi¢ed to date. In addition, a somatostatin-like
receptor, SLC-1, was identi¢ed by its homology to members
of the somatostatin receptor family [2] and subsequently
cloned from rat brain cDNA [3]. Although the SLC-1 receptor
shares 40% identity with the SSTRs in the TM domains, it
was neither activated by somatostatin-14 (SST14) nor soma-
tostatin-28 (SST28). Here, we report the identi¢cation of the
cognate ligand for SLC-1 by a ‘reverse physiology’ (also called
‘reverse pharmacology’) strategy using rat brain extracts and a
sensitive screening system in which SLC-1 is functionally co-
expressed with G protein-gated inwardly rectifying potassium
channels (GIRKs) in Xenopus oocytes. Upon several puri¢ca-
tion steps, followed by mass spectrometric analysis and pep-
tide sequencing, the ligand was identi¢ed as melanin concen-
trating hormone (MCH), revealing that the orphan SLC-1 is
the MCH receptor.
2. Materials and methods
2.1. Expression in Xenopus oocytes
For functional expression in Xenopus oocytes, rat SLC-1 cDNA
was subcloned in the Xenopus expression vector pGEMHE which
contains Xenopus L-globin 5P- and 3P-untranslated regions [4].
cRNA was in vitro transcribed using T7-RNA-polymerase and a
NheI-linearized plasmid and co-injected with GIRK1 cRNA essen-
tially as described previously [5]. For recording, oocytes were super-
fused with ND-96 medium (96 mM NaCl, 2 mM KCl, 2.5 mM CaCl2,
1 mM MgSO4, 5 mM HEPES, pH 7.5) and whole cell-clamped at 360
mV. For agonist measurements, the medium was changed to high K+
medium (hK, ND-96 with 96 mM KCl and 2 mM NaCl). After the
initial inward current had reached a plateau, agonists were applied in
the same medium. Agonist treatment was terminated by wash-out
with hK and a subsequent switch to ND-96 medium.
2.2. Extraction of rat brain peptides
For the puri¢cation of the native ligand of the SLC-1 receptor,
51 rat brains (67 g) were homogenized with an Ultra-Turrax in a
solution with 0.5 M acetic acid, 10 mM ascorbic acid, 1 mM
EDTA (10 ml/brain) and incubated for 10 min at 95‡C to precipitate
proteins. After 30 min centrifugation at 14 000Ug at 4‡C, the super-
natant fraction was applied to C18-SepPak cartridges (Waters,
Eschborn, Germany), washed with 5 ml 0.1% tri£uoroacetic acid
(TFA) and eluted with 80% methanol, 0.1% TFA. Peptides were
lyophilized, dissolved in 0.1 M acetic acid and size-fractionated using
a Sephadex G-25 column. Aliquots of fractions were concentrated
with a vacuum centrifugator (SpeedVac), dissolved in hK medium
and tested for SLC-1 agonist activity. Active fractions were further
separated with a MonoS cation exchange column (Pharmacia, Frei-
burg, Germany) linked to a LKB high performance liquid chromatog-
raphy (HPLC) system. Peptides were eluted at a linear gradient from
10 mM to 1 M ammonium formiate (pH 4.0). Active fractions were
further separated with a C18 reverse phase HPLC column (Spherisorb
OD52, Higgins Analytical, Mountain View, USA) and two runs on a
C4 reverse phase HPLC column (Vydac, The Separations Group,
Hesperia, CA, USA).
2.3. Peptide analysis
The HPLC-puri¢ed peptides were analyzed by matrix-assisted laser
desorption/ionization mass spectrometry (Re£ex, Bruker Daltonics,
Bremen, Germany) with K-cyano-4-hydroxy-cinnamic acid as matrix.
The sequences of the peptides were determined by automated Edman
degradation (model 473, PE Biosystems, Foster City, USA). Synthetic
human/rat MCH and 13Phe, 19Tyr-MCH were obtained by the Amer-
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ican Peptide Company (Sunnyvale, CA, USA) and Bachem (Hann-
over, Germany), respectively.
3. Results and discussion
In order to identify the cognate ligand for the orphan SLC-
1, the latter was co-expressed together with GIRK in Xenopus
oocytes. Fractions of the crude rat brain extract induced a
strong GIRK-mediated inward current in oocytes expressing
the rat SLC-1 receptor. No response was detected in control
oocytes injected with GIRK cRNA only (Fig. 1). The crude
rat brain extract was puri¢ed by Sephadex G-25 chromatog-
raphy and cation exchange chromatography. The active frac-
tions were combined and run on a C18 reverse phase HPLC
yielding two active fractions, F72 and F84 (Fig. 2A). Both
fractions were puri¢ed to homogeneity after two additional
runs on a C4 reverse phase HPLC (Fig. 2B and C). Mass
spectrometry revealed single masses with main peaks of
2009.08 and 2386.2 Da, respectively (Fig. 2D). Sequence anal-
ysis of the two peptides was performed using an automated
amino acid sequencer. 13 Amino acid residues were identi¢ed
matching the N-terminus of MCH (Table 1). Together with
the mass spectrometric analysis, the data indicate that the
peptide of fraction 72 consists of NH2-Met-Leu-Arg-Xaa-
Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Xaa-Xaa-Gln-Xaa and
Fig. 1. Currents induced by rat brain extract, passed through a Se-
phadex G-25 column, recorded from Xenopus oocytes expressing
SLC-1 and GIRK1 (A) and GIRK1 only (B). Downward open ar-
rows, switch from ND-96 to hK medium; upward ¢lled arrows,
fraction application (10 Wl aliquot of 4 ml total G-25 fraction 8,
concentrated and dissolved in 2 ml hK, application of 1 ml to each
oocyte); upward open arrows, wash-out with hK; downward ¢lled
arrows, switch to ND-96.
Fig. 2. Puri¢cation of the cognate ligand of SLC-1 using rat brain peptide extracts. Active fractions from the MonoS cation exchange column
were applied to a reverse phase HPLC (C18) and eluted with a linear gradient from 0 to 70% acetonitrile, 0.1% TFA (1 ml/min, 10^100 min).
Activity was detected in two fractions, F72 and F84 (A). Both fractions were puri¢ed to homogeneity after two more reverse phase HPLC
runs on a C4 column, ¢nal puri¢cation was achieved with a step wise gradient (0^10 min/14^21% acetonitrile, 0.1% TFA; 10^55 min/21^53%
acetonitrile, 0.1% TFA; 55^60 min/53^70% acetonitrile, 0.1% TFA). With this gradient, the activity of F72 elutes with 30% acetonitrile (B) and
of F84 with 37.5% acetonitrile (C). Activities of respective fractions are indicated by a bar. (D) Puri¢ed peptides were analyzed with mass spec-
trometry and relative masses of 2009.08 Da for F72 and 2386.2 Da for F84 were detected.
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the peptide of fraction 84 of NH2-Asp-Phe-Asp-Met-Leu-Arg-
Xaa-Met-Leu-Gly-Arg-Val-Tyr-Arg-Pro-Xaa-Xaa-Xaa-Xaa.
Position 4 of the peptide of fraction 72 and 7 of the peptide of
fraction 84 could not be determined, suggestive for a Cys
residue at the respective positions. As indicated in Table 1,
the peptide of fraction 84 is reminiscent to the 19 amino acid
peptide MCH, whereas that of fraction 72 is apparently a
truncated version lacking the three N-terminal amino acid
residues. Both peptides show a similar ligand activity when
tested in the frog oocyte expression system, suggesting that
the N-terminal Asp-Phe-Asp of MCH is not essential for the
GIRK-mediated inward potassium current. Whether or not
the shorter MCH version is of biological relevance or just a
degradation product obtained during puri¢cation remains to
be seen.
To verify the puri¢cation results, the synthetic peptides
MCH and a modi¢ed MCH peptide (13Phe, 19Tyr) were ana-
lyzed in the frog expression system. Dose-response curves re-
vealed an EC50 value of 2.3 nM for the native MCH peptide
and of 5 nM for the modi¢ed MCH peptide, respectively (Fig.
3), strongly suggesting that the orphan SCL-1 is the MCH
receptor.
The activation of GIRK currents in the Xenopus oocyte
system is suggestive for a Gi-coupled signal transduction path-
way for the MCH receptor. When the MCH receptor was
expressed in oocytes, alone high nM concentrations of
MCH were also able to activate Ca2-induced chloride cur-
rents (not shown), suggestive for activation of the phospholi-
pase C pathway. Thus, the MCH receptor may couple to Gi
or Gq protein.
The cyclic peptide MCH was ¢rst isolated from salmon
pituitary glands on the basis of its telling paling property of
teleost melanophore. More recently, MCH became of partic-
ular interest due to its proposed role in the regulation of food
intake behavior and associated pathologies such as obesity [6^
9]. The MCH receptor described here will certainly help to
unravel the precise function of MCH as neurotransmitter in
various brain circuits.
During submission of this manuscript, the identi¢cation of
MCH as cognate ligand for the SLC-1 receptor was published
independently by two other groups both using transfected
mammalian cells [10,11].
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Fig. 3. Dose-response curves for the native mammalian MCH and
the modi¢ed MCH. Agonist-activated GIRK currents were meas-
ured as described for Fig. 1, peak currents were normalized against
maximum currents obtained for each oocyte. Four oocytes were in-
dependently measured for each agonist. The dose-response data
were then subjected to non-linear regression analysis using the
GraphPad Prism software (GraphPad, San Diego, CA, USA). EC50
values were 2.3 nM for native MCH (triangles) and 5 nM for the
modi¢ed MCH (squares), respectively.
Table 1
Alignment of the isolated brain peptides with native and modi¢ed
MCH
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